TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"
TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"
TT BioPharm 已收到一項授予歐洲專利號 EP3283620 的決定,該專利號爲 “改性伽瑪三角洲細胞及其用途(用於治療人類癌症或傳染病)”
EP About this file - European Patent Register (epo.org)
EP 關於此文件-歐洲專利註冊局 (epo.org)
![Image](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240322/0-c69b13861a89f199c276bba81a77efd4-0-a7fc5e6ed317063f460ca73f8d46f720.jpg/big)